Related references
Note: Only part of the references are listed.MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
Keun Hur et al.
GUT (2013)
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer
Rene Jackstadt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer
Martha L. Slattery et al.
MOLECULAR CARCINOGENESIS (2013)
FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer
Alberto Pelaez-Garcia et al.
PLOS ONE (2013)
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
R. Y-J Huang et al.
CELL DEATH & DISEASE (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
EMT is the dominant program in human colon cancer
Andre Loboda et al.
BMC MEDICAL GENOMICS (2011)
MicroRNAs in colorectal cancer metastasis
Inge de Krijger et al.
JOURNAL OF PATHOLOGY (2011)
Cyclin K and cyclin D1b are oncogenic in myeloma cells
Veronique Marsaud et al.
MOLECULAR CANCER (2010)
δ-catenin affects the localization and stability of p120-catenin by competitively interacting with E-cadherin
Ilhwan Yang et al.
MOLECULES AND CELLS (2010)
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
B. Cambien et al.
BRITISH JOURNAL OF CANCER (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
CUX1 and E2F1 Regulate Coordinated Expression of the Mitotic Complex Genes Ect2, MgcRacGAP, and MKLP1 in S Phase
Laetitia Seguin et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Sp2 regulates interferon-γ-mediated socs1 gene expression
Martine Letourneur et al.
MOLECULAR IMMUNOLOGY (2009)
The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer
Simone Spaderna et al.
CANCER RESEARCH (2008)
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
Cameron P. Bracken et al.
CANCER RESEARCH (2008)
Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
Feng-Ju Huang et al.
CANCER RESEARCH (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to elongin BC-based ubiquitin ligases
Nawel Mahrour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Lanlan Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells
A. Sirvent et al.
ONCOGENE (2007)
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
Gregory J. Hurteau et al.
CANCER RESEARCH (2007)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice
Toshikatsu Hanada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
JAW/STAT signal transduction: Regulators and implication in hematological malignancies
L Valentino et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
P Dhawan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
A Eger et al.
ONCOGENE (2005)
Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients
S Fujitake et al.
JOURNAL OF GASTROENTEROLOGY (2004)
STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes
J Travagli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases
T Kamura et al.
GENES & DEVELOPMENT (2004)
SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis
T Yoshida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma
Z Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
A core function for p120-catenin in cadherin turnover
MA Davis et al.
JOURNAL OF CELL BIOLOGY (2003)
Regulation of cytokine receptor signaling by SOCS1
S Ilangumaran et al.
IMMUNOLOGICAL REVIEWS (2003)
A novel role for p120 catenin in E-cadherin function
RC Ireton et al.
JOURNAL OF CELL BIOLOGY (2002)
Regulation of socs gene expression by the proto-oncoprotein GFI-1B -: Two routes for STAT5 target gene induction by erythropoietin
AG Jegalian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
H Yoshikawa et al.
NATURE GENETICS (2001)
Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation
J Frantsve et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
